Stay updated on Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied and the government funding/operating status notice was removed, with no changes to study content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T10:59:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a general notice about government funding lapse and NIH Clinical Center operations; updated site revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T10:30:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now includes a Show glossary option and a new 'Last Update Submitted that Met QC Criteria' field, along with a footer displaying 'No FEAR Act Data' and 'Revision: v3.4.0'. The previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:21:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T02:13:04.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations data was reorganized: state locations (California, Delaware, Florida, Georgia, Louisiana, Maryland, Oklahoma, Tennessee, Washington) were removed and a generic Locations header added; the page revision updated to v3.3.3, and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.8%
    Check dated 2025-12-23T20:26:25.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    A minor version update is visible: Revision: v3.3.2 was added and Revision: v3.2.0 was removed, with no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:55:17.000Z thumbnail image

Stay in the know with updates to Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial page.